Phase II, Dose-Response, Safety and Efficacy Study of Oral TMX-67 in Subjects With Gout.
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00002438/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine the efficacy of febuxostat, once daily (QD), in reducing serum urate levels in subjects with gout.
提供机构：
Vivli
创建时间：
2018-10-27
